<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0585">
 <label>117</label>
 <element-citation publication-type="other" id="rf0505">
  <person-group person-group-type="author">
   <name>
    <surname>Kongsaengdao</surname>
    <given-names>D.S.</given-names>
   </name>
  </person-group>
  <article-title>A 6 week prospective, open label, randomized, in Multicenter Study of, Oseltamivir Plus Hydroxychloroquine Versus Lopipinavir/Ritonavir Plus Oseltamivir Versus Darunavir/Ritonavir Plus Oseltamivir Plus Hydroxychloroquine in Mild COVID-19 AND Lopipinavir/Ritonavir Plus Oseltamivir Versus Favipiravir Plus Lopipinavir/Ritonavir Versus Darunavir/Ritonavir Plus Oseltamivir Plus Hydroxychloroquine Versus Favipiravir Plus Darunavir and Ritonavir Plus Hydroxychloroquine in Moderate to Critically Ill COVID-19, clinicaltrials.gov</article-title>
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04303299" id="ir0505" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04303299</ext-link>
  <year>2020</year>
 </element-citation>
</ref>
